Pharmacokinetics after endovascular lung perfusion with cisplatin

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 5, 2006, Pages 883-888

  Brown, Daniel B ^a,c   Cai, Shi Rong ^b,c   Fundakowski, Christopher E ^d   Zamboni, William C ^e   Strychor, Sandy ^e   McLeod, Howard L ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BALLOON OCCLUSION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG INFUSION; DRUG TISSUE LEVEL; DRUG UPTAKE; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG PERFUSION; LUNG TUMOR; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SWINE; ANIMAL; BALLOON DILATATION; DNA ADDUCT; METABOLISM; METHODOLOGY; RANDOMIZATION; REGIONAL PERFUSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BALLOON DILATATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; DNA ADDUCTS; LUNG NEOPLASMS; PLATINUM; PULMONARY ARTERY; RANDOM ALLOCATION; SWINE;

EID: 33745017439     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000209346.88944.17     Document Type: Article

References (39)

1. Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999; 229:602-610.
2. Chao C, Goldberg M. Surgical treatment of metastatic pulmonary soft-tissue sarcoma. Oncology 2000; 14:835-841.
3. Robinson MH, Sheppard M, Moskovic E, et al. Lung metastasectomy in patients with soft tissue sarcoma. Br J Radiol 1994; 67:129-135.
4. Putnam JB. New and evolving treatment methods for pulmonary metastases. Semin Thorac Cardiovasc Surg 2002; 14:49-56.
5. Creech O, Krementz ET, Ryan RF, et al. Experiences with isolation-perfusion technics in the treatment of cancer. Ann Surg 1959; 149:627-640.
6. Nawata S, Abolhoda A, Ross HM, et al. Sequential bilateral isolated lung perfusion in the rat: an experimental model. Ann Thorac Surg 1997; 63:796-799.
7. Abolhoda A, Brooks A, Nawata S, et al. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 1997; 64:181-184.
8. Brown DB, Ma MK, Battafarano RJ, et al. Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal model. Oncol Rep 2004; 11:237-243.
9. Furrer M, Lardinois D, Thormann W, et al. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique. Ann Thorac Surg 1998; 65:1523-1528.
10. Hendriks JM, Van Schil PE, Van Oosterom AA, et al. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma. Eur Surg Res 1999; 31:267-271.
11. Kaneda Y, Liu D, Brooks A, et al. Toxicity and pharmacokinetics of isolated lung perfusion with cisplatin in rat. Jpn J Thorac Cardiovasc Surg 2001; 49:443-448.
12. Ratto GB, Esposito M, Leprini A, et al. In situ lung perfusion with cisplatin: an experimental study. Cancer 1993; 71:2962-2970.
13. Saeki K, Kaneda Y, Li TS, et al. Relationship between the concentration of CDDP in tumor and tumor size after isolated lung perfusion treatment experimental study on a solitary pulmonary sarcoma model in rats. J Surg Oncol 2000; 75:193-196.
14. Tanaka T, Kaneda Y, Li TS, et al. Digitonin enhances the antitumor effect of cisplatin during isolated lung perfusion. Ann Thorac Surg 2001; 72:1173-1178.
15. Van Putte BP, Hendriks JM, Romijn S, et al. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg 2002; 74:893-898.
16. Van Putte BP, Hendriks JM, Romijn S, et al. Pharmacokinetics after pulmonary artery perfusion with gemcitabine. Ann Thorac Surg 2003; 76:1036-1040.
17. Van Putte BP, Hendriks JM, Romijn S, et al. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. J Surg Res 2003; 109:118-122.
18. Wang HY, Ng B, Blumberg D, et al. Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model. Ann Thorac Surg 1995; 60:1390-1394.
19. Weksler B, Blumberg D, Lenert JT, et al. Isolated single-lung perfusion with TNF-alpha in a rat sarcoma lung metastases model. Ann Thorac Surg 1994; 58:328-331.
20. Weksler B, Lenert J, Ng B, et al. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg 1994; 107:50-54.
21. Weksler B, Ng B, Lenert JT, et al. Isolated single-lung perfusion: a study of the optimal perfusate and other pharmacokinetic factors. Ann Thorac Surg 1995; 60:624-629.
22. Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995; 110:368-373.
23. Burt ME, Liu D, Abolhoda A, et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 2000; 69:1542-1549.
24. Minchin RF, Johnston MR, Aiken MA, et al. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. J Pharmacol Exp Ther 1984; 229:193-198.
25. Zamboni WC, Gervais AC, Egorin MJ, et al. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin. Clin Cancer Res 2002; 8:2992-2999.
26. Kohne CH, Cunningham D, Di CF, et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 2002; 13:308-317.
27. Van Putte BP, Hendriks JM, Romijn S, et al. Isolated lung perfusion for the treatment of pulmonary metastases current mini-review of work in progress. Surg Oncol 2003; 12:187-193.
28. Ratto GB, Toma S, Civalleri D, et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996; 112:614-622.
29. Abolhoda A, Brooks A, Choudhry M, et al. Characterization of local inflammatory response in an isolated lung perfusion model. Ann Surg Oncol 1998; 5:87-92.
30. Li TS, Kaneda Y, Saeki K, et al. Pharmacokinetic differences between rat tumour and lung tissues following isolated lung perfusion with cisplatin. Eur J Cancer 1999; 35:1846-1850.
31. Solomon B, Soulen M, Baum R, et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999; 10:793-798.
32. Brown DB, Fundakowski CE, Lisker-Melman M, et al. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2004; 15:1209-1218.
33. Kerber CW, Wong WH, Howell SB, et al. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. Am J Neuroradiol 1998; 19:935-941.
34. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000; 22:687-693.
35. Franke UFW, Wittwer T, Lessel M, et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity. Eur J Cardiothorac Surg 2004; 26:792-799.
36. Franke UF, Wittwer T, Kaluza M, et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue. Eur J Cardiothorac Surg 2004; 26:800-806.
37. Merimsky O, Hirsh L, Dantes A, et al. Induction of apoptosis in non-small lung carcinoma cell line (H1299) by combination of anti-asthma drugs with gemcitabine and cisplatin. Int J Oncol 2005; 26:475-482.
38. De Marinis F, Nelli F, Lombardo M, et al. A multicenter, randomized, phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma. Cancer 2005; 103:772-779.
39. Vogl TJ, Wetter A, Lindemayr S, et al. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 2005; 234:917-922.